The kidney transplantation program in Norway since 2000.

Area of Science:

• Nephrology
• Transplantation Medicine
• Public Health

Background:

• The number of transplants per million population has reached 60.8, positioning Europe at the forefront of organ transplantation.
• The rise in kidney transplants since 2000 is primarily attributed to enhanced deceased organ donation rates.
• A waiting list of under 50 per million inhabitants for deceased donor kidney transplantation signifies a high transplant success rate.

Purpose of the Study:

• To evaluate the efficacy and safety of renal transplantation as a treatment for end-stage kidney failure.
• To assess the suitability of renal transplantation for elderly patients (over 70).
• To determine the optimal timing for kidney transplantation in relation to dialysis initiation.

Main Methods:

• Analysis of organ transplantation statistics across Europe.
• Review of clinical outcomes for renal transplant recipients, including those over 70.
• Assessment of donor organ quality, considering age and biopsy findings.

Main Results:

• Renal transplantation is confirmed as a safe and effective treatment for end-stage kidney failure.
• Transplantation is a viable option for patients over 70, provided they meet medical criteria.
• Transplanting organs from older or suboptimal donors yields very good outcomes.
• Pre-transplant organ function is a more critical predictor of success than kidney biopsy results.

Conclusions:

• Renal transplantation is a highly successful treatment for end-stage kidney disease, with increasing rates in Europe.
• Elderly patients and those receiving organs from suboptimal donors can achieve excellent transplant outcomes.
• Timely transplantation, ideally before or early in dialysis, maximizes patient benefit.